|
|
|
Insider
Information: |
Hastings Paul J |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
258,381 |
|
Indirect Shares
|
6,636 |
|
|
Direct
Value |
$264,756 |
|
|
Indirect Value
|
$20,505 |
|
|
Total
Shares |
265,017 |
|
|
Total
Value |
$285,261 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
6
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
5
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-131.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Novelion Therapeutics Inc |
NVLN |
President & CEO, Direc... |
2005-04-29 |
9,500 |
|
0 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2023-06-14 |
8,374 |
2013-05-15 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2014-06-19 |
0 |
Premium* |
|
Protara Therapeutics, Inc |
TARA |
Director |
|
0 |
2016-10-18 |
6,636 |
Premium* |
|
Nkarta, Inc. |
NKTX |
|
2024-03-04 |
240,507 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2014-10-10 |
4 |
AS |
$94.87 |
$237,175 |
D/D |
(2,500) |
853 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2015-01-12 |
4 |
AS |
$94.06 |
$235,150 |
D/D |
(2,500) |
853 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2015-04-10 |
4 |
AS |
$88.00 |
$220,000 |
D/D |
(2,500) |
853 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2014-07-10 |
4 |
AS |
$82.46 |
$211,017 |
D/D |
(2,500) |
853 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2021-03-05 |
4 |
S |
$65.88 |
$197,640 |
D/D |
(3,000) |
6,116 |
0 |
% |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2021-06-04 |
4 |
AS |
$62.19 |
$39,180 |
D/D |
(630) |
5,486 |
0 |
% |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2015-08-17 |
4 |
AS |
$60.02 |
$180,060 |
D/D |
(3,000) |
2,853 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2015-11-20 |
4 |
AS |
$60.00 |
$180,000 |
D/D |
(3,000) |
2,853 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2016-02-17 |
4 |
AS |
$60.00 |
$180,000 |
D/D |
(3,000) |
2,853 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2022-07-11 |
4 |
AS |
$56.95 |
$30,354 |
D/D |
(533) |
7,179 |
0 |
% |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2020-06-04 |
4 |
S |
$47.46 |
$96,107 |
D/D |
(2,025) |
4,856 |
0 |
% |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2016-06-06 |
4 |
AS |
$46.95 |
$53,335 |
D/D |
(1,136) |
1,717 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2019-06-04 |
4 |
AS |
$42.66 |
$33,360 |
D/D |
(782) |
2,747 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2023-05-15 |
4 |
AS |
$41.85 |
$292,950 |
D/D |
(7,000) |
7,179 |
0 |
% |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2023-06-05 |
4 |
S |
$38.34 |
$22,237 |
D/D |
(580) |
6,599 |
0 |
% |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2017-08-22 |
4 |
S |
$36.15 |
$37,741 |
D/D |
(1,044) |
3,518 |
0 |
- |
|
RLYP |
Relypsa Inc |
Director |
|
2015-06-11 |
4 |
AS |
$34.63 |
$50,359 |
D/D |
(1,454) |
3,508 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2018-06-04 |
4 |
S |
$33.90 |
$26,137 |
D/D |
(771) |
2,747 |
0 |
- |
|
RLYP |
Relypsa Inc |
Director |
|
2016-09-01 |
4 |
D |
$32.00 |
$79,840 |
D/D |
(2,495) |
2,250 |
0 |
- |
|
RLYP |
Relypsa Inc |
Director |
|
2016-09-01 |
4 |
D |
$32.00 |
$72,000 |
D/D |
(2,250) |
0 |
0 |
- |
|
NKTX |
Nkarta, Inc. |
Chief Executive Officer |
|
2021-03-30 |
4 |
AS |
$30.23 |
$522,540 |
D/D |
(17,000) |
236,061 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2023-05-15 |
4 |
OE |
$29.90 |
$209,300 |
D/D |
7,000 |
14,179 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-05-15 |
4 |
B |
$29.30 |
$24,993 |
D/D |
853 |
853 |
2.39 |
- |
|
NKTX |
Nkarta, Inc. |
Chief Executive Officer |
|
2021-09-29 |
4 |
AS |
$26.53 |
$231,051 |
D/D |
(8,500) |
219,061 |
0 |
- |
|
NKTX |
Nkarta, Inc. |
Chief Executive Officer |
|
2021-06-21 |
4 |
AS |
$26.39 |
$226,219 |
D/D |
(8,500) |
227,561 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|